MedPath

Laromustine

Generic Name
Laromustine
Drug Type
Small Molecule
Chemical Formula
C6H14ClN3O5S2
CAS Number
173424-77-6
Unique Ingredient Identifier
14J2G0U3NQ

Overview

VNP40101M is a novel alkylating agent that has been used in trials studying the treatment of Leukemia, Lymphoma, Lung Cancer, Small Intestine Cancer, and Myelodysplastic Syndromes, among others.

Background

VNP40101M is a novel alkylating agent that has been used in trials studying the treatment of Leukemia, Lymphoma, Lung Cancer, Small Intestine Cancer, and Myelodysplastic Syndromes, among others.

Indication

Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), colorectal cancer, leukemia (lymphoid), leukemia (myeloid), lung cancer, myelodysplastic syndrome, pediatric indications, and solid tumors.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2009/02/10
Phase 1
Completed
Institut Paoli-Calmettes
2008/04/09
Phase 1
Terminated
2007/08/28
Phase 1
Completed
2007/08/15
Phase 1
Terminated
2006/07/20
Phase 2
UNKNOWN
Vion Pharmaceuticals
2006/03/17
Phase 1
Completed
Vion Pharmaceuticals
2006/01/25
Phase 2
Completed
Vion Pharmaceuticals
2005/06/03
Phase 3
Completed
Vion Pharmaceuticals
2004/12/09
Phase 1
Completed
Pediatric Brain Tumor Consortium
2004/12/08
Phase 1
Completed
Vion Pharmaceuticals

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath